Aortic regurgitation surgery overview: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:


The majority of patients with severe aortic regurgitation requiring surgery undergo [[aortic valve replacement]] instead of [[aortic valve repair]] which is sometimes preformed at highly specialized surgical centers which have appropriate technical expertise and experience in selecting potential patients.
The majority of patients with severe aortic regurgitation requiring surgery undergo [[aortic valve replacement]] instead of [[aortic valve repair]] which is sometimes preformed at highly specialized surgical centers which have appropriate technical expertise and experience in selecting potential patients.
==Selecting A Mechanical Verssus a Bioprosthetic Valve==
The 2006 American College of Cardiology/American Heart Association ([[ACC]]/[[AHA]]) recommendations for the choice of aortic valve <ref name="pmid18820172">{{cite journal| author=Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al.| title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=Circulation | year= 2008 | volume= 118 | issue= 15 | pages= e523-661 | pmid=18820172 | doi=10.1161/CIRCULATIONAHA.108.190748 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18820172  }} </ref><ref name="pmid17259184">{{cite journal| author=Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G et al.| title=Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. | journal=Eur Heart J | year= 2007 | volume= 28 | issue= 2 | pages= 230-68 | pmid=17259184 | doi=10.1093/eurheartj/ehl428 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17259184  }} </ref>:
*If the patient is under 65 years of age and does not have a contraindication to anticoagulation then a mechanical valve is preferred.
*If the patient is ≥65 years of age and does not have risk factors for thromboembolism, then a bioprosthetic valve is reasonable
*If the patient already has a mechanical valve in the mitral or tricuspid position and already requires anticoagulation, then a mechical valve is preferred
*If the patient has active prosthetic valve endocarditis, then the valve should be replaced
*If the patient has contraindications to anticoagulation therapy regardless his or her age, then a bioprosthetic valve is indicated


==References==
==References==

Revision as of 13:30, 15 April 2012

Aortic Insufficiency Surgery

Home

Overview

Indications

Treatment

Preoperative Evaluation

Valve selection

Procedure

Recovery

Outcomes & Prognosis

Complications

Videos

Aortic regurgitation surgery overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic regurgitation surgery overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic regurgitation surgery overview

CDC on Aortic regurgitation surgery overview

Aortic regurgitation surgery overview in the news

Blogs on Aortic regurgitation surgery overview

Directions to Hospitals Performing Aortic insufficiency Surgery

Risk calculators and risk factors for Aortic regurgitation surgery overview

For the WikiPatient page for this topic, click here; For the main page of aortic insufficiency, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief:Mohammed A. Sbeih, M.D.[2]

Related Key Words and Synonyms: Aortic valve replacement.

Overview

Aortic valve replacement is indicated in patients with severe aortic insufficiency who are either symptomatic or those who have a left ventricular end-diastolic diameter >55 mm or 25 mm/m2 or an left ventricular ejection fraction <55%.

The majority of patients with severe aortic regurgitation requiring surgery undergo aortic valve replacement instead of aortic valve repair which is sometimes preformed at highly specialized surgical centers which have appropriate technical expertise and experience in selecting potential patients.

Selecting A Mechanical Verssus a Bioprosthetic Valve

The 2006 American College of Cardiology/American Heart Association (ACC/AHA) recommendations for the choice of aortic valve [1][2]:

  • If the patient is under 65 years of age and does not have a contraindication to anticoagulation then a mechanical valve is preferred.
  • If the patient is ≥65 years of age and does not have risk factors for thromboembolism, then a bioprosthetic valve is reasonable
  • If the patient already has a mechanical valve in the mitral or tricuspid position and already requires anticoagulation, then a mechical valve is preferred
  • If the patient has active prosthetic valve endocarditis, then the valve should be replaced
  • If the patient has contraindications to anticoagulation therapy regardless his or her age, then a bioprosthetic valve is indicated

References

  1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172.
  2. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G; et al. (2007). "Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology". Eur Heart J. 28 (2): 230–68. doi:10.1093/eurheartj/ehl428. PMID 17259184.

Template:WH Template:WS